Blog
RSS FeedPosted by Michael Wonder on 03 May 2022
Boehringer Ingelheim Canada announces reimbursement for Ofev (nintedanib) in seven public drug plans for the treatment of progressive fibrosing interstitial lung diseases
3 May 2022 - Boehringer Ingelheim is pleased to announce that Ofev (nintedanib), is now available for public reimbursement in Quebec, ...
Posted by Michael Wonder on 02 May 2022
Prices of Tecentriq, Avastin go down due to broader insurance benefits
2 May 2022 - The Government granted health insurance benefits to the combination therapy of Tecentriq and Avastin to treat ...
Posted by Michael Wonder on 01 May 2022
COVID-19 oral treatment listed on PBS from 1 May 2022
1 May 2022 - This prescription only oral treatment has been found to be effective in treating mild to moderate ...
Posted by Michael Wonder on 01 May 2022
Schedule of Pharmaceutical Benefits - 1 May 2022
1 May 2022 - The May 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 May 2022
New Pharmaceutical Benefits Scheme listings to save patients millions
1 May 2022 - Health Minister Greg Hunt has announced a series of new Pharmaceutical Benefits Scheme listings which will save ...
Posted by Michael Wonder on 01 May 2022
New Zealand Pharmaceutical Schedule - 1 May 2022
1 May 2022 - The May 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 09 Apr 2022
PBS listing of Paxlovid (nirmatrelvir and ritonavir)
9 April 2022 - Commencing 1 May 2022, Paxlovid (nirmatrelvir and ritonavir) will be listed on the PBS as a General ...
Posted by Michael Wonder on 31 Mar 2022
Schedule of Pharmaceutical Benefits - 1 April 2022
1 April 2022 - The April 2022 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Mar 2022
New Zealand Pharmaceutical Schedule -1 April 2022
1 April 2022 - The April 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 26 Mar 2022
Landmark PBS listing for Australians with cystic fibrosis
27 March 2022 - From April 1 2022, Trikafta (elexacaftor with tezacaftor and ivacaftor and ivacaftor) will be available on ...
Posted by Michael Wonder on 25 Mar 2022
Expanded PBS listing for lung disease medication
25 March 2022 - The Australian Government is helping more Australians access the medications they need with a new addition to ...
Posted by Michael Wonder on 02 Mar 2022
BeiGene hits major milestone with first PBS approved cancer treatment
1 March 2022 - BeiGene is welcoming the listing of Brukinsa (zanubrutinib), a targeted treatment for mantle cell lymphoma, an aggressive ...
Posted by Michael Wonder on 01 Mar 2022
New PBS listings from 1 March 2022
1 March 2022 - Australians will have access to four new medicines through the Pharmaceutical Benefits Scheme from March 1 to ...
Posted by Michael Wonder on 28 Feb 2022
New Zealand Pharmaceutical Schedule - 1 March 2022
1 March 2022 - The March 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 28 Feb 2022
Lagevrio (molnupiravir) PBS listing
1 March 2022 - Commencing 1 March 2022, Lagevrio (molnupiravir) will be listed on the PBS Section 85 program as an ...